Dental prescribing of antibiotics and opioids: high use in the absence of evidence
抗生素和阿片类药物的牙科处方:在缺乏证据的情况下大量使用
基本信息
- 批准号:10166019
- 负责人:
- 金额:$ 27.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Antibiotics and opioids are the top therapeutic categories prescribed by Dentists. Interestingly, factors associ-
ated with prescribing behaviors of these medication classes are similar. Our preliminary data on dental pre-
scribing demonstrates that high prescribers of opioids are also high prescribers of antibiotics. However, there
is a current knowledge gap in our understanding of medication prescribing and overprescribing (for inappro-
priate indications and/or excessive quantity/potency/duration) by Dentists. This gap is significant because
Dentists prescribe 1 out of every 10 prescriptions (Rx) for both antibiotics and opioids in the US. Inappro-
priate and appropriate use of antibiotic and opioids are a risk to patient safety, including: bacterial resistance,
Clostridium difficile infection, opioid overdose, drug dependence and diversion. Opioid overprescribing is con-
cerning because substance users commonly seek opioids from dentists, dentists infrequently use prescription
drug monitoring programs (PDMP) and fatalities secondary to opioid use have been linked to dental prescrib-
ing. Use of antibiotics for infection prophylaxis prior to dental procedures has been associated with C. difficile.
Guidelines for infective endocarditis and prosthetic joint infection prophylaxis during dental procedures were
recently updated, significantly reducing the number of patients requiring antibiotic prophylaxis. However, de-
spite infection prophylaxis being the primary indication for antibiotics prescribed by dentists, our preliminary
data shows only a small (0.7%) decrease in overall dental antibiotic prescribing. Although efforts are increas-
ing to curtail inappropriate use of these medication classes, most interventions are focused on physicians and
midlevel providers (nurse practitioners, physician assistants). Guided by preliminary data, we will be pursuing
[2] specific aims: 1) [Assess] dental prescribing of antibiotics and opioid medications and identify patient
and prescriber characteristics associated with high rates of overprescribing and 2) [Compare attitudes to-
wards prescribing antibiotics and opioids for dentist with practices located in high and low prescribing com-
munities across the United States.] The proposed study is aligned with the research priority areas of AHRQ
(safer health care; improvements in health care practice, especially in ambulatory care) and 2 White House
National Action Plans focused on antibiotic resistance and adverse drug events associated with opioid use.
We propose to conduct a mixed-methods study to assess antibiotic and opioid dental prescribing based on
American Dental Association treatment recommendations and identify factors related to prescribing. The ex-
pected outcomes of this study include providing baseline data on the extent of antibiotic and opioid overpre-
scribing by dentists, identification of barriers and facilitators to improving prescribing of antibiotics and opioids
and selection of a pilot implementation project to improve the quality of dental care. Our long-term goal is to
improve patient dental care by implementing interventions that will increase prudent antimicrobial use, de-
crease opioid overprescribing and decrease serious adverse events.
抗生素和阿片类药物是牙科医生开出的主要治疗类别。有趣的是,相关因素-
使用处方时,这些药物类别的行为是相似的。我们关于牙科治疗前的初步数据
划线表明,阿片类药物的高处方者也是抗生素的高处方者。然而,在那里
目前在我们对药物处方和过度处方的理解上存在知识差距(对于不合适的
适当的适应症和/或过量的数量/效力/持续时间)。这一差距是显著的,因为
在美国,牙医对抗生素和阿片类药物的处方(处方)每10张中就有1张。伊纳普罗-
适当使用抗生素和阿片类药物对患者安全构成风险,包括:细菌耐药性,
艰难梭菌感染,阿片类药物过量,药物依赖和转移。阿片类药物过量处方是反-
由于吸毒者通常向牙医寻求阿片类药物,牙医很少使用处方
药物监测计划(PDMP)和阿片类药物使用继发的死亡与牙科处方有关-
英。在牙科手术前使用抗生素预防感染与艰难梭菌有关。
牙科手术中感染性心内膜炎和人工关节感染预防指南如下
最近更新,显著减少了需要抗生素预防的患者数量。然而,去-
尽管预防感染是牙医开出的抗生素的主要适应症,但我们的初步报告
数据显示,牙科抗生素处方总数仅有小幅下降(0.7%)。尽管努力在增加-
为了减少不适当地使用这些药物类别,大多数干预措施都集中在医生和
中层提供者(执业护士、医生助理)。在初步数据的指引下,我们将继续
[2]具体目标:1)[评估]抗生素和阿片类药物的牙科处方并确定患者
和与高过量处方率相关的处方者特征和2)[比较对-
为牙科医生开抗生素和阿片类药物的病房,其做法位于高处方和低处方的组合。
美国各地的社区活动。]拟议的研究与AHRQ的研究优先领域保持一致
(更安全的保健;改进保健做法,特别是在非卧床护理方面)和2白宫
国家行动计划侧重于抗生素耐药性和与阿片类药物使用有关的不良药物事件。
我们建议进行一项混合方法研究,以评估抗生素和阿片类药物的牙科处方
美国牙科协会的治疗建议,并确定与处方相关的因素。前任-
这项研究的预期结果包括提供抗生素和阿片类药物过量程度的基线数据。
牙医划线,确定障碍和促进因素,以改善抗生素和阿片类药物的处方
并选择一个试点实施项目,以提高牙科保健的质量。我们的长期目标是
通过实施干预措施改善患者的牙科护理,以增加谨慎的抗菌药物使用,减少
减少阿片类药物过量使用,减少严重不良事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KJ Suda其他文献
KJ Suda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KJ Suda', 18)}}的其他基金
The broken drug supply chain: The impact of COVID-19 on drug shortages and Veteran health
断裂的药品供应链:COVID-19 对药品短缺和退伍军人健康的影响
- 批准号:
10637004 - 财政年份:2023
- 资助金额:
$ 27.05万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 27.05万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 27.05万 - 项目类别:
Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids
通过加强抗生素和阿片类药物的牙科管理来改善退伍军人的健康
- 批准号:
10186541 - 财政年份:2018
- 资助金额:
$ 27.05万 - 项目类别:
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
抗生素和阿片类药物的牙科处方:在缺乏证据的情况下大量使用
- 批准号:
9753146 - 财政年份:2017
- 资助金额:
$ 27.05万 - 项目类别:
相似海外基金
Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by Dentists
了解和减少牙医不适当抗生素处方的信息学方法
- 批准号:
10736908 - 财政年份:2023
- 资助金额:
$ 27.05万 - 项目类别:
Antibiotic Prescribing Implementation Laboratory (APrIL)
抗生素处方实施实验室 (APrIL)
- 批准号:
481561 - 财政年份:2023
- 资助金额:
$ 27.05万 - 项目类别:
Operating Grants
Development, Validation and Real-World Application of Comprehensive Metrics to Improve Hospitals' Antibiotic Prescribing
改善医院抗生素处方的综合指标的开发、验证和实际应用
- 批准号:
10636459 - 财政年份:2023
- 资助金额:
$ 27.05万 - 项目类别:
Personalized AI Model for Antibiotics Prescribing
抗生素处方的个性化人工智能模型
- 批准号:
2734592 - 财政年份:2022
- 资助金额:
$ 27.05万 - 项目类别:
Studentship
Antibiotic Prescribing in Patients with COVID-19: A Rapid Review with Meta-Analysis and Meta-Regression
COVID-19 患者的抗生素处方:荟萃分析和荟萃回归的快速回顾
- 批准号:
466530 - 财政年份:2021
- 资助金额:
$ 27.05万 - 项目类别:
Studentship Programs
Evaluating a Prescribing Feedback System for Acute Care Providers
评估急性护理提供者的处方反馈系统
- 批准号:
10515631 - 财政年份:2020
- 资助金额:
$ 27.05万 - 项目类别:
Addressing conflict of interest driving irrational prescribing of antibiotics in pluralistic health systems: an interventional study in Pakistan
解决多元卫生系统中导致抗生素不合理处方的利益冲突:巴基斯坦的一项干预性研究
- 批准号:
MR/T02349X/1 - 财政年份:2020
- 资助金额:
$ 27.05万 - 项目类别:
Research Grant
Evaluating a Prescribing Feedback System for Acute Care Providers
评估急性护理提供者的处方反馈系统
- 批准号:
10237198 - 财政年份:2020
- 资助金额:
$ 27.05万 - 项目类别:
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
抗生素和阿片类药物的牙科处方:在缺乏证据的情况下大量使用
- 批准号:
9753146 - 财政年份:2017
- 资助金额:
$ 27.05万 - 项目类别:
Optimizing Testosterone Prescribing in the VA
优化退伍军人事务部的睾酮处方
- 批准号:
10186475 - 财政年份:2016
- 资助金额:
$ 27.05万 - 项目类别: